{"id":"W2986283446","doi":"10.25251/skin.3.supp.38","title":"Nail Outcome Improvements with Certolizumab Pegol in Moderate to Severe Plaque Psoriasis: Results from Phase 3 Trials","year":2019,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"","keywords":"Certolizumab pegol; Medicine; Plaque psoriasis; Psoriasis; Nail (fastener); Dermatology; Outcome (game theory); Internal medicine; Infliximab; Tumor necrosis factor alpha; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009442305,0.0003326475,0.001292304,0.0002596913,0.00009342669,0.00001206384,0.000459378,0.0001991226,0.0006756787],"category_scores_gemma":[0.0006037958,0.0001634316,0.000132319,0.000220489,0.00008121947,0.00008934942,0.0000470453,0.0004267138,0.0001841949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001321701,"about_ca_system_score_gemma":0.0001350416,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005118183,"about_ca_topic_score_gemma":0.0002536135,"domain_scores_codex":[0.9967054,0.0008839889,0.001554163,0.0002607467,0.0001988721,0.0003968205],"domain_scores_gemma":[0.99669,0.001599075,0.001014821,0.0004507153,0.0001660848,0.00007930567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4577616,0.001939892,0.003361454,0.00007523,0.006414649,0.008692917,0.0293253,0.001196525,0.2763993,0.00005803592,0.01784167,0.1969334],"study_design_scores_gemma":[0.5484016,0.05219344,0.003226383,0.00469904,0.008350138,0.1147299,0.01723202,0.000148917,0.1858414,0.002467755,0.06023131,0.002478103],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893681,0.001623206,0.00006977749,0.005178492,0.002111797,0.0007520156,0.0002266397,0.00001505536,0.000654929],"genre_scores_gemma":[0.9957656,0.0003258185,0.0001043579,0.0002996592,0.0003481475,0.000007615065,0.00006888507,0.00002897068,0.003050922],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1944553,"threshold_uncertainty_score":0.7398207,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03094004696178332,"score_gpt":0.2977013145001826,"score_spread":0.2667612675383993,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}